Keywords: GLP-1 RA;Tilpotide;Tilposide;GIP\GLP-1;Tirzepatide;Trizepatide;terzapitide;tirzepatide 10mg;Tirzepatide(GLP-1);Trizepatide peptide

Product Name：Tirzepatide

CasNo：2023788-19-2

Molecular Formula：C225H348N48O68

Molecular Weight：4813 g/mol

Appearance：White powder

Application：Treatment of type 2 diabetes

Package：According to customer’s requirements

About JYMed：

Shenzhen JYMed Technology Co., Ltd. (hereinafter referred to as JYMed) was established in 2009, specializing in the research, development, production, and sales of peptides and peptide-related products. With one research center and three major production bases, JYMed is one of the largest producers of chemically synthesized peptide APIs in China. The company’s core R&D team boasts over 20 years of experience in the peptide industry and has successfully passed FDA inspections twice. JYMed’s comprehensive and efficient peptide industrialization system offers customers a full range of services, including the development and production of therapeutic peptides, veterinary peptides, antimicrobial peptides, and cosmetic peptides, as well as registration and regulatory support.

Main Business Activities

1.Domestic and international registration of peptide APIs

2.Veterinary and cosmetic peptides

3.Custom peptides and CRO, CMO, OEM services

4.PDC drugs (peptide-radionuclide, peptide-small molecule, peptide-protein, peptide-RNA)

Contact Us

Shenzhen JYMed Technology Co., Ltd.

Address: 8th & 9th Floors, Building 1, Shenzhen Biomedical Innovation Industrial Park, No. 14 Jinhui Road, Kengzi Subdistrict, Pingshan District, Shenzhen

Phone: +86 755-26612112

Website: http://www.jymedtech.com/